The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Baseline demographics of patients with neuroendocrine tumors presenting to seven National Comprehensive Cancer Network (NCCN) institutions: Development of a multi-institutional outcomes database.
Michael A. Choti
No relevant relationships to disclose
Margaret A. Mayorga
No relevant relationships to disclose
Sarah Bobiak
No relevant relationships to disclose
Matthew Kulke
Consultant or Advisory Role - Ipsen; Lexicon; Molecular Insight Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis
James C. Yao
No relevant relationships to disclose
Emily K. Bergsland
Consultant or Advisory Role - Novartis (U); Pfizer (U)
Research Funding - Genentech; Novartis; OSI Pharmaceuticals
Eric K. Nakakura
No relevant relationships to disclose
Mark Bloomston
No relevant relationships to disclose
Al Bowen Benson
No relevant relationships to disclose
Manisha H. Shah
No relevant relationships to disclose
Jonathan R. Strosberg
Consultant or Advisory Role - Novartis
Honoraria - Genentech
Research Funding - Novartis; Pfizer